Search Results 7371-7380 of 34239 for oral

1. A Study To Evaluate The Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderate To Severe Crohn's Disease (MK-7240-008) - Mayo Clinic

   * Demonstrated inadequate response, loss of response, or intolerance to one or more of the following categories of drugs: oral locally acting steroids ...

2. A Study to Assess Metabolic Changes in the Blood with Standard Treatment in Patients with Gliomas - Mayo Clinic

   Patients who will be proceeding to receive routine standard of care treatment (radiation with concurrent oral temozolomide) at Mayo Clinic, Rochester.

3. Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer - Mayo Clinic

   This study is designed for patients with a cancer of the oropharynx (tonsils or base of tongue) caused by the HPV virus. Traditional treatment involves surgery ...

4. Publications - Derek J. Lomas, M.D. - Mayo Clinic

   Treatment of Influenza with Oral Antivirals Journal of the Iowa Pharmacy Association. 2009; 65(4):42-47. PST-20460940. Home; Publications. National Doctors ...

5. Rebecca L. Johnson, M.D. - Doctors and Medical Staff - Mayo Clinic

   ExaminerPractice Oral Board, Anesthesia Residents, Department of Anesthesiology and Perioperative Medicine. 2010 - 2011. MemberEducation Executive-Resident ...

6. Study of GS-5290 in Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

   of randomization; or any infection requiring oral anti-infective therapy within 6 weeks of randomization. History of opportunistic infection. Current ...

7. Germs: Understand and protect against bacteria, viruses and infections - Mayo Clinic

   The immune system protects against things that cause infections, called infectious agents. But some germs keep changing to get past the immune system's defenses ...

8. Publications - Lilly H. Wagner, M.D. - Mayo Clinic

   Delayed periorbital hemorrhage in oculoplastic surgery patients on oral anticoagulants. Orbit. 2021 Apr; 40 (2):150-154 Epub 2020 Apr 15. View PubMed; Vicente ...

9. A Study to Evaluate the Safety of Lixivaptan in Subjects Previously Treated with Tolvaptan for Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   oral contraceptives;; double barrier methods of non-hormonal contraception are permitted in this study: female condom with spermicide (cream, spray, gel ...

10. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

    Patient is receiving oral anti-metabolite chemotherapy during the maintenance phase of therapy; treatment plan must call for the following doses of ...